KALI SULPH
KALI SULPH is an FDA drug label for the active ingredient POTASSIUM SULFATE manufactured by Hyland's Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20221219.
Generic: POTASSIUM SULFATE
Manufacturer: Hyland's Inc.
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 54973-5230
Application:
Effective: 20221219
Active Ingredients: FORMULA Kali Sulphuricum 6X HPUS In a base of Acacia Gum, Lactose N.F.
Indications & Usage
INDICATIONS Relief of symptoms of the common cold. Relief of symptoms of pimples and blemishes associated with common acne.
Dosage & Administration
DIRECTIONS Adults & Children ages 6 - 12: 4 tablets. Children ages 2 - 6: 2 tablets. Dissolve under tongue 3 times a day. Use more frequently (every 15 minutes for up to 8 doses) with acute conditions.
Contraindications
Not available.
Warnings
Warnings Do not use if imprinted cap band is broken or missing. If symptoms persist for more than seven days or worsen, contact a licensed health care provider. Discontinue use if symptoms are accompanied by a high fever (over 101° F). If you are pregnant or nursing, seek the advice of a licensed health care provider before using this product. Keep this and all medications out of the reach of children.
Adverse Reactions
Not available.
More from same ingredient
KALIUM SULFURICUM 6X
Seroyal USA
Kali sulphuricum
Boiron
Kali sulphuricum
Boiron
Kali sulphuricum
Boiron
Kali sulphuricum
Boiron
Kali sulphuricum
Boiron
Kali sulphuricum
Boiron